ORIC Pharmaceuticals, Inc. (ORIC) Tops Q4 EPS by 7c
Tweet
Share
E-mailGet Alerts ORIC Hot Sheet
Join SI Premium – FREE
ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) reported Q4 EPS of ($0.30), $0.07 better than the analyst estimate of ($0.37).
For earnings history and earnings-related data on ORIC Pharmaceuticals, Inc. (ORIC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- HSBC Upgrades Sembcorp Industries (SCI:SP) to Buy
- UBS Upgrades Pagegroup Plc. (PAGE:LN) (MPGPY) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
